Here we evaluated: 1) the effect of COVID-19 on EC activation (NOX2 activation and ROS production), 2) the role of NOX2-ROS in driving the pro-inflammatory phenotype of EC and 3) the effect of PIP-2 on these signaling events. Here, CYBB is linked to COVID-19.